Allergan Aesthetics, an AbbVie company (NYSE:ABBV), announced on Wednesday that Natrelle has been named as a supplier by Vizient Inc, a healthcare performance improvement company.

This agreement connects Natrelle to Vizient's extensive network of academic medical centres, community hospitals, integrated delivery networks, and non-acute care providers, representing more than half of US healthcare organisations.

Under the contract, Vizient clients will gain enhanced access to Natrelle's offerings, including more than 300 implant options within the most comprehensive breast implant line. Allergan said that providers will also receive competitive pricing, a simplified procurement process, greater operational efficiency, and direct support from the brand's sales and technical teams.